FQ
TTPH

First Quadrant’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

First Quadrant’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,834
Closed -$148K – 862
2016
Q4 		$148K Buy
1,834
+1,043
+132% +$82.5K ﹤0.01% 668
2016
Q3 		$61K Buy
+791
New +$63.4K ﹤0.01% 765

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Quadrant's TTPH Position: Q1 2017 in Review

First Quadrant sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2017, closing a stake of 1,834 shares — an estimated $148K sold.

First Quadrant first reported a position in TTPH in Q3 2016 and held it in 2 quarters. The position peaked at $148K in Q4 2016. 89 funds tracked by Wall St. Rank hold TTPH as of Q1 2017.

  • First Quadrant reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • First Quadrant sold 1,834 Tetraphase Pharmaceuticals, Inc. shares in Q1 2017, an estimated $148K.
  • First Quadrant first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • First Quadrant's Tetraphase Pharmaceuticals, Inc. position peaked at $148K in Q4 2016.
  • 89 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2017.

Based on First Quadrant's 13F filing for Q1 2017, filed 25 Apr 2017.